MOPEAD newsletter 01

Project Coordinator, Dr Mercè Boada will present MOPEAD at the 43rd World Hospital Congress in Muscat, Oman from the 6th - 9th November. 

Dr. Boada will present a poster on the MOPEAD objectives, the main methods used during the testing of the four differen...

The NEURONET project is organising its annual networking and communication event this week in The Hague to showcase the best of IMI's neurodegeneration portfolio. 

Project coordinator, Dr. Mercè Boada will present the MOPEAD project in a parallel sessi...

Saturday 21st September marks World Alzheimer Day 2019, an important international event which aims to raise awareness about dementia. Over the whole month of September, Alzheimer’s Disease International (ADI) launched a global campaign under the them...

Cambridge Cognition (CANTAB) presented an interim analysis of the MOPEAD Projects innovative citizen science patient engagement model at the Alzheimer’s Association International Conference (AAIC) 2019, Los Angles USA. This conference is the largest and mo...

The Spanish magazine for geriatric care professionals, GeriatricArea, recently published an article on MOPEAD highlighting it's nomination for the 2019 Internet Awards. 

MOPEAD was named as a finalist for the award in the category of "Research and...

The MOPEAD team is thrilled to announce that the renowned journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association published an article on the foundations and the structure of the MOPEAD Project. 

The article presents an in-depth analysis...

The MOPEAD Communication team is pleased to present the 2nd MOPEAD newsletter which brings all the latest news from the project together including an introduction from our Patient Association partner Spominčica - Alzheimer Slovenija and articles on the var...

 You can now watch the presentations given at the MOPEAD Symposium at the 28th Alzheimer Europe Conference on Alzheimer Europe's YouTube channel.

Watch project Coordinator Mercè Boada (Fundació ACE) present MOPEAD's rationale and objectives to understa...

Please reload

Please reload

©2018 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations